Data from First Phase III Clinical Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A, the PLEO-CMT Trial, Published in the Orphanet Journal of Rare Diseases
PARIS, FRANCE / ACCESSWIRE / October 18, 2021 / Pharnext SA (FR0011191287 – ALPHA) (the…
Hoot Host is “The Wiser Way” to Grow Online
Deveron Completes Transaction to Sell Its Assets
Fonar Announces Financial Results for The 2nd Quarter of Fiscal 2026